Naso (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Naso, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Naso as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory documentation for importers.

Xylometazoline Hydrochloride is used as a topical nasal decongestant to reduce swelling of the nasal mucosa.

Common cold: provides rapid relief of nasal blockage caused by viral upper‑respiratory infection. Sinusitis: decreases mucosal edema, improving sinus drainage and easing congestion. Allergic rhinitis: alleviates nasal obstruction associated with allergen‑induced inflammation.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging sensation in the nose. - Nasal dryness or crusting. - Sneezing or mild irritation. - Headache (occasionally).

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) after prolonged use. - Elevated blood pressure or hypertension. - Tachycardia or palpitations. - Severe allergic reactions such as rash, swelling, or anaphylaxis.

When using Naso, several safety considerations should be observed to minimize risks.

Duration of use: limit to no more than three consecutive days to avoid rebound congestion. Age restrictions: not recommended for children under 6 years without medical advice. Cardiovascular conditions: avoid in patients with uncontrolled hypertension or severe heart disease. Pregnancy and lactation: use only if clearly needed and prescribed by a healthcare professional. Drug interactions: consult a physician before combining with other nasal decongestants or systemic sympathomimetics. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medicines, influencing its safety or effectiveness.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis when combined with sympathomimetic agents. - Other nasal decongestants (e.g., phenylephrine, oxymetazoline): additive vasoconstriction may increase systemic side effects. - Systemic alpha‑adrenergic agonists (e.g., pseudoephedrine): may cause excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs (beta‑blockers, ACE inhibitors): nasal decongestant may reduce their blood‑pressure‑lowering effect. - Cocaine or other nasal irritants: combined use can exacerbate nasal mucosal damage. - Tricyclic antidepressants: may potentiate sympathomimetic effects, requiring monitoring.